Boehringer Ingelheim today announced results from two new analyses of the phase III RE-VERSE AD™ study, which evaluated the safety and efficacy of idarucizumab, marketed in the U.S. as...

With multiple demonstrations of success helping insurers augment their Guidewire InsuranceSuite™ applications and achieve their digital transformation goals, Hyland welcomes...

Women who took estrogen-only hormone replacement therapy after ovary removal had a lower risk of developing glaucoma, according to research presented today at AAO 2017, the 121st Annual Meeting of...

Iron Mountain Incorporated (NYSE: IRM), the storage and information management services company, announced that William L. Meaney, President and CEO, and Stuart Brown, Executive Vice President and...

NexPoint Residential Trust, Inc. (NYSE: NXRT) ("NXRT") announced today that Brian Mitts, NXRT's Chief Financial Officer, Executive VP-Finance and Treasurer, Matt McGraner, NXRT's Executive VP and...

A new kind of eyedropper can deliver tiny droplets of medication, treating the eye more precisely than traditional eyedroppers, while reducing waste and avoiding dangerous side effects. According...

Amgen (NASDAQ:AMGN) today announced five new subgroup analyses from the Repatha® (evolocumab) cardiovascular outcomes study (FOURIER) that showed the addition of Repatha to statin therapy...

SC17 -- News summary Dell EMC combines high-performance computing and data analytics with advances in machine and deep learning, enabling enterprises to address opportunities in areas such as...

Michael Thomas, Vice President at Gershman Mortgage and Co-Chair of the Affordable Housing Colorado Fall Conference will be a panel speaker at the upcoming Novogradac Low-Income Housing Tax Credit...

The regenerative LANAP protocol has changed the standard of care for treating gum disease. Although gum disease is an epidemic -- 85% of U.S. adults live with it -- most patients don't realize...